Table 5.

TCP and NTCP of different plans for patients with EBRT and without EBRT

		TCP, α/β=1.5 Gy		TCP, α/β=3 Gy		TCP, α/β=10 Gy
		Prostate-DILa	DIL	Prostate-DIL	DIL	Prostate-DIL	DIL
Patients with EBRT (8)	I b	89.3 ± 4.8	61.7 ± 28.5	85.2 ± 6.2	50.4 ± 33.2	63.3 ± 11.7	25.3 ± 33.0
	II	87.8 ± 4.9	83.6 ± 13.9	83.4 ± 6.1	75.9 ± 19.8	60.5 ± 11.5	45.8 ± 33.9
	III	87.4 ± 6.0	90.1 ± 7.5	83.1 ± 6.9	85.2 ± 11.3	60.7 ± 12.1	59.1 ± 27.1
	P-values
	I vs II	0.250	0.008	0.195	0.016	0.250	0.008
	I vs III	0.469	0.016	0.469	0.016	0.297	0.016
	II vs III	0.297	0.031	0.219	0.031	0.219	0.031
Patients without EBRT (9)	I	94.8 ± 0.7	89.5 ± 16.9	91.1 ± 1.1	84.5 ± 21.0	70.8 ± 2.9	63.0 ± 25.3
	II	94.5 ± 1.1	96.1 ± 5.2	90.6 ± 1.6	93.5 ± 8.4	69.9 ± 4.1	80.3 ± 19.6
	III	94.3 ± 1.4	97.3 ± 3.0	90.3 ± 2.2	95.3 ± 5.2	69.0 ± 5.5	84.8 ± 14.9
	P-values
	I vs II	0.258	0.004	0.250	0.004	0.426	0.004
	I vs III	0.219	0.004	0.301	0.004	0.359	0.004
	II vs III	0.805	0.008	0.734	0.008	0.652	0.008
		NTCP
		Bladder		Rectum		Uretha
Patients with EBRT (8)	I	10.5 ± 9.8		0		71.0 ± 2.1
	II	11.1 ± 7.3		0		72.1 ± 1.8
	III	8.5 ± 4.2		0		71.8 ± 1.8
		P-values
	I vs II	0.945		N/A		0.008
	I vs III	0.938		N/A		0.016
	II vs III	0.297		N/A		0.688
Patients without EBRT (9)	I	0.1 ± 0.2		0		46.1 ± 5.9
	II	0.5 ± 1.2		0		48.4 ± 6.3
	III	0.2 ± 0.4		0		48.9 ± 6.9
		P-values
	I vs II	0.652		N/A		0.004
	I vs III	0.570		N/A		0.008
	II vs III	0.426		N/A		0.250

^aProstate - DIL = Prostate with DIL cropped.

^bI, II and III are “Original”, “Original Boost” and “Additional Boost” plans, respectively.